Dry-Needling for Lower Back Pain

N/A

Recruiting

Led By Dominic Severino, PT,DPT

Research Sponsored by Whitworth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must also report an Oswestry Disability Index score of at least 20/100 points.

Be between 18 and 65 years old

Must not have

Those participants whose BMI is greater than 35

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 1, week 2 and week 3

Summary

This trial aims to find out which specific clinical characteristics of people with low back pain make them suitable for a treatment called Intermuscular Dry-Needling (IMDN). The researchers also want to

Who is the study for?

This trial is for individuals experiencing lower back pain. It aims to find out which patients are likely to benefit from a treatment called Intramuscular Dry-Needling (IMDN).

What is being tested?

The study is testing the effectiveness of IMDN in treating low back pain and developing a tool to predict who will respond well to this therapy.

What are the potential side effects?

Possible side effects of IMDN may include temporary soreness, bruising at the needle site, muscle aches, or minor bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My back pain affects my daily activities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My BMI is over 35.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 1, week 2 and week 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 1, week 2 and week 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 1, week 2 and week 3 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Oswestry Disability Index

Secondary study objectives

11 point Numeric Pain-Rating Scale

Fear-Avoidance Beliefs Questionnaire

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Intramuscular Dry-NeedlingExperimental Treatment1 Intervention

(IMDN) is a minimally invasive procedure where a solid filament needle is inserted into a myofascial trigger point.

Group II: Sham Intramuscular Dry-NeedlingPlacebo Group1 Intervention

). Park sham acupuncture needles (AcuPrime) will be used to perform sham needling for this group. The sham needle functions by allowing the blunted needle to cause a pricking sensation when pushed against the skin, but does not penetrate. This will allow the patient to perceive that the needle is entering the skin while also maintaining therapist-patient contact and interaction time

0 / 2Eligibility criteria met